Innoculator

Innoculator: Protecting Your Unpatched Software with AI-Powered Security

Innoculator is a cutting-edge security solution designed to safeguard unpatched or legacy software from cyber threats. By combining the power of artificial intelligence with agentless application protection, Innoculator helps organizations mitigate risks associated with unpatched vulnerabilities and legacy systems.

Benefits

Innoculator offers several key advantages for organizations struggling with unpatched software and legacy applications:

• AI-Driven Protection: Uses artificial intelligence to generate signatures for known vulnerabilities, providing virtual patching for unpatched software.
• Agentless Security: Does not require the installation of agents on protected systems, reducing the burden on IT infrastructure.
• Centralized Management: Integrates with existing systems and allows for centralized control and adjustment of network security posture.
• Automated Remediation: Automatically assigns signatures to continuously monitor and update designated workloads, ensuring ongoing protection.

Use Cases

Innoculator is particularly useful for organizations facing the following challenges:

• Legacy Applications: Protects legacy systems that cannot be easily patched or updated, reducing the risk of exploitation.
• Limited Patching Resources: Helps organizations with limited budgets or resources to manage and implement patches effectively.
• Increasing Threat Landscape: Provides an additional layer of security against evolving cyber threats targeting unpatched vulnerabilities.

Additional Information

Innoculator is owned and developed by Tech Optional Pty Ltd, a company founded by cybersecurity veterans with over 40 years of combined experience. The solution is now available for trial download, and the company is actively seeking partnerships globally. Innoculator's founders emphasize the importance of teamwork and solid foundations in building successful partnerships.

For more information or to express interest in partnering with Innoculator, visit their website or reach out to them directly.